Structural insights into the HBV receptor and bile acid transporter NTCP
Jae-Hyun Park,
Masashi Iwamoto,
Ji-Hye Yun,
Tomomi Uchikubo-Kamo,
Donghwan Son,
Zeyu Jin,
Hisashi Yoshida,
Mio Ohki,
Naito Ishimoto,
Kenji Mizutani,
Mizuki Oshima,
Masamichi Muramatsu,
Takaji Wakita,
Mikako Shirouzu,
Kehong Liu,
Tomoko Uemura,
Norimichi Nomura,
So Iwata,
Koichi Watashi,
Jeremy R. H. Tame,
Tomohiro Nishizawa,
Weontae Lee () and
Sam-Yong Park ()
Additional contact information
Jae-Hyun Park: Yokohama City University
Masashi Iwamoto: National Institute of Infectious Diseases
Ji-Hye Yun: Yonsei University
Tomomi Uchikubo-Kamo: RIKEN Center for Biosystems Dynamics Research
Donghwan Son: Yonsei University
Zeyu Jin: Yokohama City University
Hisashi Yoshida: Yokohama City University
Mio Ohki: Yokohama City University
Naito Ishimoto: Yokohama City University
Kenji Mizutani: Yokohama City University
Mizuki Oshima: National Institute of Infectious Diseases
Masamichi Muramatsu: National Institute of Infectious Diseases
Takaji Wakita: National Institute of Infectious Diseases
Mikako Shirouzu: RIKEN Center for Biosystems Dynamics Research
Kehong Liu: Kyoto University
Tomoko Uemura: Kyoto University
Norimichi Nomura: Kyoto University
So Iwata: Kyoto University
Koichi Watashi: National Institute of Infectious Diseases
Jeremy R. H. Tame: Yokohama City University
Tomohiro Nishizawa: Yokohama City University
Weontae Lee: Yonsei University
Sam-Yong Park: Yokohama City University
Nature, 2022, vol. 606, issue 7916, 1027-1031
Abstract:
Abstract Around 250 million people are infected with hepatitis B virus (HBV) worldwide1, and 15 million may also carry the satellite virus hepatitis D virus (HDV), which confers even greater risk of severe liver disease2. The HBV receptor has been identified as sodium taurocholate co-transporting polypeptide (NTCP), which interacts directly with the first 48 amino acid residues of the N-myristoylated N-terminal preS1 domain of the viral large protein3. Despite the pressing need for therapeutic agents to counter HBV, the structure of NTCP remains unsolved. This 349-residue protein is closely related to human apical sodium-dependent bile acid transporter (ASBT), another member of the solute carrier family SLC10. Crystal structures have been reported of similar bile acid transporters from bacteria4,5, and these models are believed to resemble closely both NTCP and ASBT. Here we have used cryo-electron microscopy to solve the structure of NTCP bound to an antibody, clearly showing that the transporter has no equivalent of the first transmembrane helix found in other SLC10 proteins, and that the N terminus is exposed on the extracellular face. Comparison of our structure with those of related proteins indicates a common mechanism of bile acid transport, but the NTCP structure displays an additional pocket formed by residues that are known to interact with preS1, presenting new opportunities for structure-based drug design.
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/s41586-022-04857-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:606:y:2022:i:7916:d:10.1038_s41586-022-04857-0
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-022-04857-0
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().